These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2992718)

  • 1. The noradrenergic neurotoxins DSP4 and xylamine bind to opiate receptors.
    Wilkinson M; Jacobson W; Wilkinson DA
    Brain Res Bull; 1985 May; 14(5):493-5. PubMed ID: 2992718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct effects of the adrenergic neurotoxin DSP4 on central opiate receptors: implications for neuroendocrine studies.
    Jacobson W; Wilkinson M; Gibson CJ
    Exp Brain Res; 1985; 59(3):570-4. PubMed ID: 2993014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of xylamine binding to proteins of PC12 pheochromocytoma cells.
    Koide M; Cho AK; Howard BD
    J Neurochem; 1986 Oct; 47(4):1277-85. PubMed ID: 3746302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active and passive avoidance following the administration of systemic DSP4, xylamine, or p-chloroamphetamine.
    Archer T; Jonsson G; Ross SB
    Behav Neural Biol; 1985 May; 43(3):238-49. PubMed ID: 3842248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat.
    Jonsson G; Hallman H; Sundström E
    Neuroscience; 1982; 7(11):2895-907. PubMed ID: 7155358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neurons.
    Hallman H; Jonsson G
    Eur J Pharmacol; 1984 Aug; 103(3-4):269-78. PubMed ID: 6237924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of oocyte release in rats by local administration of the noradrenergic neurotoxin DSP4.
    Goldman JM; Stoker TE; Cooper RL; McElroy WK; Parrish MB
    J Reprod Fertil; 1996 Mar; 106(2):275-83. PubMed ID: 8699411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of destruction of central noradrenergic and serotonergic nerve terminals by systemic neurotoxins on the long-term effects of antidepressants on beta-adrenoceptors and 5-HT2 binding sites in the rat cerebral cortex.
    Hall H; Ross SB; Sällemark M
    J Neural Transm; 1984; 59(1):9-23. PubMed ID: 6325593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mu-opioid ([3H]DAGO) binding in slices of rat brain: inhibition by sodium ions, guanyl-5'-yl imidodiphosphate and by the adrenergic neurotoxins DSP4 and xylamine.
    Wilkinson M; Wilkinson DA; Jacobson W
    Neuropeptides; 1987; 9(4):357-71. PubMed ID: 3614559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lesion of noradrenergic neurones with DSP4 does not modify benzodiazepine receptor binding in cortex and hippocampus of rat.
    Marcel D; Bardelay C; Hunt PF
    Neuropharmacology; 1986 Mar; 25(3):283-6. PubMed ID: 3010165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurotoxic compound N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP4) depletes endogenous norepinephrine and enhances release of [3H]norepinephrine from rat cortical slices.
    Landa ME; Rubio MC; Jaim-Etcheverry G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):131-6. PubMed ID: 6491970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The depletion of rat cortical norepinephrine and the inhibition of [3H]norepinephrine uptake by xylamine does not require monoamine oxidase activity.
    Dudley MW
    Life Sci; 1988; 43(23):1871-7. PubMed ID: 3143879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of xylamine on the uptake of [3H]dopamine into isolated striatal synaptosomes of the rats.
    Liang P; Chang SS; Cheng JT
    Neurosci Lett; 1993 Apr; 153(2):181-4. PubMed ID: 8392155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the noradrenergic neurotoxin DSP4 on growth and the gonadal steroid- and PMSG-induced release of LH in the prepubertal female rat.
    Jacobson W; Wilkinson M; Gibson CJ
    Brain Res Bull; 1988 May; 20(5):643-9. PubMed ID: 3382969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of xylamine on the uptake of [3H]norepinephrine into primary astrocyte cultures.
    Chang TK; Cheng JT
    Brain Res; 1992 Nov; 597(1):162-5. PubMed ID: 1477731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of DSP4 and desipramine in the sensorial and affective component of neuropathic pain in rats.
    Bravo L; Mico JA; Rey-Brea R; Camarena-Delgado C; Berrocoso E
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():57-67. PubMed ID: 27181607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of rat cerebral cortical opiate receptors following chronic desimipramine treatment.
    Reisine T; Soubrie P
    Eur J Pharmacol; 1982 Jan; 77(1):39-44. PubMed ID: 6277652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine alters opiate receptor binding in critical brain reward regions.
    Hammer RP
    Synapse; 1989; 3(1):55-60. PubMed ID: 2537540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [N-2-chloroethyl-N-ethyl-2-bromobenzylamine (DSP4) increases the liberation of 3H-noradrenaline produced by depolarization of the nerve ending].
    Landa ME; Rubio MC; Jaim-Etcheverry G
    Acta Physiol Pharmacol Latinoam; 1988; 38(2):167-80. PubMed ID: 2847491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DSP4-induced two-way active avoidance impairment in rats: involvement of central and not peripheral noradrenaline depletion.
    Archer T; Ogren SO; Johansson G; Ross SB
    Psychopharmacology (Berl); 1982; 76(4):303-9. PubMed ID: 6812102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.